U.K MHRA asked for then open label data, Canada IO also would look at OLE data, certainly phillipines since we got the ball rolling over there with actually small CD-10 trial + EIND data. Now they have CD-12 and OLE and 29+ Filipino patients. Also Brazil is getting hammered they might not want to wait for new pvalue to prove it saves life’s, get severe criticals out of the hospital 6 days quicker than any drug currently approved.

Also I believe leronlimab is the very best ease of use Covid-19 therapeutic for Severe critical patients. One could receive a quick simple shot. I’ve stopped caring about FDA that is basically a guaranteed approval that will take several months. I am focusing my vision much like CYDY is on the more immediate short term possibilities of EUA and instant revenues in multiple other countries where covid is spiraling out of control.